Concepedia

Alan Anthoney

AA

Statistics

Publications

78

Citations

16K

H-Index

41

Active since

1995

Affiliations

St James's University Hospital(Current)

The Christie NHS Foundation Trust

Beatson West of Scotland Cancer Centre

Leeds Teaching Hospitals NHS Trust

University of Manchester

Alan Anthoney is an author at St James's University Hospital specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1995–2025

78

Publications

78

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

, , +12

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh et al. · The Lancet · 2017 · 1.9K citations · Full text

, , +17

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

, , +9

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan et al. · The Lancet Oncology · 2021 · 749 citations · Full text

, , +8

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al. · JAMA · 2012 · 592 citations

, , +17

1–5 of 78